NURSING MISC EXAM 2023 QUESTIONS WITH ANSWERS GRADED
A ASSUARED SUCCESS
Hematologic/CV
Question 1. Beta blockers (BBs) are generally contraindicated in
which patient?
The patient who has unstable asthma
Question 2. Which of these represents a rare adverse reaction
associated with cardiac glycosides (CGs)?
Gynecomastia
Question 3. The APN is initiating an HMG-CoA reductase inhibitor.
Which statement by the patient demonstrates understanding of the
education of the drug?
“I will return in 6 to 8 weeks to repeat my lipid panel bloodwork.”
Question 4. Which drug increases lipolysis of triglycerides via
lipoprotein lipase, resulting in a decrease of 50% or more in triglyceride
levels?
Fibric acid derivatives
Question 5. A patient taking warfarin for treatment of deep vein
thrombosis (DVT) presents to the clinic with a fungal infection requiring
treatment with antifungal agent. The APN recognizes that there is an
interaction between many antifungal agents and warfarin. Which
action by the APN is most appropriate?
Adjust the dose of warfarin and monitor the patient’s international
normalized ratio (INR) more frequently while the patient is taking the new
medication.
Question 6. A patient presents with a transient ischemic attack (TIA)
and needs long-term anticoagulation. He reports an allergy to aspirin.
Which other medication is recommended by the American College of
Chest Physicians (ACCP)?
Clopidogrel 75 mg daily
Question 7. When would the APN expect to see an increase in
reticulocytes after a patient with chronic renal failure begins treatment
with epoetin alfa to treat anemia?
7 to 10 days
, NURSING MISC EXAM 2023 QUESTIONS WITH ANSWERS GRADED
A ASSUARED SUCCESS
Question 8. Which of these might explain a failure to maintain a
response to regular doses of epoetin alfa in a patient with chronic renal
disease?
Occult blood loss
Question 9. When educating a patient who is taking oral iron
supplements for anemia, which advice is most appropriate for the APN
to offer?
It is best to take this medication on an empty stomach.
Question 10. Which client is at lowest risk for folic acid deficiency?
A 50-year-old man who is a vegetarian
Question 11. A patient receiving chemotherapy for non-Hodgkin
lymphoma is scheduled to receive pegfilgrastim to reduce the risk of
neutropenia after his treatment. When is the best time for the patient
to receive the pegfilgrastim?
At least 24 hours after his chemotherapy session
Question 12. A 76-year-old patient with pernicious anemia is
scheduled to begin treatment for his anemia and vitamin B 12 deficiency.
In addition to anemia, he has been experiencing paresthesia in his
lower extremities and an unsteady gait. Which treatment regimen will
the APRN anticipate providing for this patient?
Hydroxocobalamin 1000 mcg injection daily for 7 days, followed by 1000
mcg weekly for 1 month, followed by 1000 mcg twice monthly for 6 months,
then monthly for the rest of his life
Question 13. Which adverse reaction is uncommon with use
of angiotensin-converting enzyme inhibitors (ACEIs)?
Neutropenia
Question 14. A patient has been started on a calcium channel blocker
(CCB). The APN should provide which instruction to the patient
regarding use of CCBs?
Notify your health-care provider if you experience unusual swelling of hands,
feet, or ankles, and/or decreased urine output.
A ASSUARED SUCCESS
Hematologic/CV
Question 1. Beta blockers (BBs) are generally contraindicated in
which patient?
The patient who has unstable asthma
Question 2. Which of these represents a rare adverse reaction
associated with cardiac glycosides (CGs)?
Gynecomastia
Question 3. The APN is initiating an HMG-CoA reductase inhibitor.
Which statement by the patient demonstrates understanding of the
education of the drug?
“I will return in 6 to 8 weeks to repeat my lipid panel bloodwork.”
Question 4. Which drug increases lipolysis of triglycerides via
lipoprotein lipase, resulting in a decrease of 50% or more in triglyceride
levels?
Fibric acid derivatives
Question 5. A patient taking warfarin for treatment of deep vein
thrombosis (DVT) presents to the clinic with a fungal infection requiring
treatment with antifungal agent. The APN recognizes that there is an
interaction between many antifungal agents and warfarin. Which
action by the APN is most appropriate?
Adjust the dose of warfarin and monitor the patient’s international
normalized ratio (INR) more frequently while the patient is taking the new
medication.
Question 6. A patient presents with a transient ischemic attack (TIA)
and needs long-term anticoagulation. He reports an allergy to aspirin.
Which other medication is recommended by the American College of
Chest Physicians (ACCP)?
Clopidogrel 75 mg daily
Question 7. When would the APN expect to see an increase in
reticulocytes after a patient with chronic renal failure begins treatment
with epoetin alfa to treat anemia?
7 to 10 days
, NURSING MISC EXAM 2023 QUESTIONS WITH ANSWERS GRADED
A ASSUARED SUCCESS
Question 8. Which of these might explain a failure to maintain a
response to regular doses of epoetin alfa in a patient with chronic renal
disease?
Occult blood loss
Question 9. When educating a patient who is taking oral iron
supplements for anemia, which advice is most appropriate for the APN
to offer?
It is best to take this medication on an empty stomach.
Question 10. Which client is at lowest risk for folic acid deficiency?
A 50-year-old man who is a vegetarian
Question 11. A patient receiving chemotherapy for non-Hodgkin
lymphoma is scheduled to receive pegfilgrastim to reduce the risk of
neutropenia after his treatment. When is the best time for the patient
to receive the pegfilgrastim?
At least 24 hours after his chemotherapy session
Question 12. A 76-year-old patient with pernicious anemia is
scheduled to begin treatment for his anemia and vitamin B 12 deficiency.
In addition to anemia, he has been experiencing paresthesia in his
lower extremities and an unsteady gait. Which treatment regimen will
the APRN anticipate providing for this patient?
Hydroxocobalamin 1000 mcg injection daily for 7 days, followed by 1000
mcg weekly for 1 month, followed by 1000 mcg twice monthly for 6 months,
then monthly for the rest of his life
Question 13. Which adverse reaction is uncommon with use
of angiotensin-converting enzyme inhibitors (ACEIs)?
Neutropenia
Question 14. A patient has been started on a calcium channel blocker
(CCB). The APN should provide which instruction to the patient
regarding use of CCBs?
Notify your health-care provider if you experience unusual swelling of hands,
feet, or ankles, and/or decreased urine output.
